SQI Diagnostics (FRA:XSQ) YoY EBITDA Growth : -66.67% (As of Mar. 2023)

View and export this data going back to 2010. Start your Free Trial

What is SQI Diagnostics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. SQI Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2023 was -66.67%.

SQI Diagnostics's EBITDA per Share for the three months ended in Mar. 2023 was €-0.01.

SQI Diagnostics YoY EBITDA Growth Historical Data

The historical data trend for SQI Diagnostics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SQI Diagnostics YoY EBITDA Growth Chart

SQI Diagnostics Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

YoY EBITDA Growth

Get a 7-Day Free Trial

11.11

18.75

34.62

-17.65

-50.00

SQI Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
YoY EBITDA Growth	Get a 7-Day Free Trial															57.14	-500.00	-125.00	16.67	-66.67

SQI Diagnostics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

SQI Diagnostics's YoY EBITDA Growth for the fiscal year that ended in Sep. 2022 is calculated as:

	YoY EBITDA Growth (A: Sep. 2022 )
=	(EBITDA per Share (A: Sep. 2022 )	-	EBITDA per Share (A: Sep. 2021 ))	/	\| EBITDA per Share (A: Sep. 2021 ) \|
=	(-0.03	-	-0.02)	/	\| -0.02 \|
=	-50.00 %

SQI Diagnostics's YoY EBITDA Growth for the quarter that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2023 )
=	(EBITDA per Share (Q: Mar. 2023 )	-	EBITDA per Share (Q: Mar. 2022 ))	/	\| EBITDA per Share (Q: Mar. 2022 )) \|
=	(-0.005	-	-0.003)	/	\| -0.003 \|
=	-66.67 %

SQI Diagnostics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of SQI Diagnostics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SQI Diagnostics (FRA:XSQ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SQI Diagnostics Inc (FRA:XSQ) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

36 Meteor Drive, Toronto, ON, CAN, M9W 1A4

Website

https://www.sqidiagnostics.com

SQI Diagnostics Inc is the leader in the field of lung health. The company develops and manufactures respiratory health and precision medicine tests that run on SQI's automated systems. The company is developing tests to simplify and improve COVID-19 antibody monitoring, rapid acute lung injury testing, donor organ transplant informatics, and immunological protein and antibody testing. Its geographical segments are the United States, Canada, and Europe. Canada accounts for more than half of its revenues.

SQI Diagnostics (FRA:XSQ) Headlines

No Headlines